CA1014472A - Cholestyramine coacervate - Google Patents

Cholestyramine coacervate

Info

Publication number
CA1014472A
CA1014472A CA179,971A CA179971A CA1014472A CA 1014472 A CA1014472 A CA 1014472A CA 179971 A CA179971 A CA 179971A CA 1014472 A CA1014472 A CA 1014472A
Authority
CA
Canada
Prior art keywords
coacervate
cholestyramine
cholestyramine coacervate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA179,971A
Other languages
English (en)
Other versions
CA179971S (en
Inventor
Gerald P. Polli
Clyde E. Shoop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1014472A publication Critical patent/CA1014472A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
CA179,971A 1972-09-01 1973-08-30 Cholestyramine coacervate Expired CA1014472A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28571972A 1972-09-01 1972-09-01

Publications (1)

Publication Number Publication Date
CA1014472A true CA1014472A (en) 1977-07-26

Family

ID=23095432

Family Applications (1)

Application Number Title Priority Date Filing Date
CA179,971A Expired CA1014472A (en) 1972-09-01 1973-08-30 Cholestyramine coacervate

Country Status (7)

Country Link
CA (1) CA1014472A (fr)
DE (1) DE2344090A1 (fr)
FR (1) FR2197592B1 (fr)
GB (1) GB1446352A (fr)
IL (1) IL43022A (fr)
NL (1) NL7311319A (fr)
ZA (1) ZA736016B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
CA1313135C (fr) * 1987-02-09 1993-01-26 The Dow Chemical Company Composition de cholestyramine et procede pour sa preparation
EP0349103B1 (fr) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Comprimé à mâcher
US4931280A (en) * 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5102664A (en) * 1989-07-19 1992-04-07 Day Charles E Good-tasting gritty drug formulations
WO1992011019A1 (fr) * 1990-12-20 1992-07-09 The Procter & Gamble Company Composition de psyllium et de cholestyramine dont le gout a ete ameliore
WO1993018756A1 (fr) * 1992-03-20 1993-09-30 The Procter & Gamble Company Compositions de resine exchangeuse d'ions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin

Also Published As

Publication number Publication date
DE2344090A1 (de) 1974-03-21
FR2197592A1 (fr) 1974-03-29
GB1446352A (en) 1976-08-18
IL43022A (en) 1976-07-30
FR2197592B1 (fr) 1976-08-13
IL43022A0 (en) 1974-01-14
NL7311319A (fr) 1974-03-05
AU5946073A (en) 1975-02-27
ZA736016B (en) 1975-04-30

Similar Documents

Publication Publication Date Title
AU5439373A (en) Pillow-doll combination
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
CA1014472A (en) Cholestyramine coacervate
AU454372B2 (en) Childsafe actuator-overcap
CA979287A (en) Handprinter construction
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
AU475339B2 (en) S-substituted-2-thiodenosines
CA999580A (en) S-triazine-imide copolymers
CA1012289A (en) Copolyester
AU470359B2 (en) Sulphamoylphenyl-imidazolidinones
AU468159B2 (en) 5-aroyl-furans
AU466344B2 (en) Cycloalkyllactamimides
CA1013370A (en) Aminoalkylethers
AU444851B2 (en) Gutter-fascia construction
AU468236B2 (en) 2-acyl-5-nitrothiazoles
AU468599B2 (en) 15-oxasteroids
AU467526B2 (en) Pyronorifamycins
AU473297B2 (en) Indolylimidoylheterocyclics
AU472554B2 (en) Isothocyanobenzoxazoles
CA1007648A (en) Plicatamides
AU480258B2 (en) Palatable cholestyramine coacervate compositions
CA899940A (en) Lock-alarm combination
CA908137A (en) Vannes de sectionnement
CA894875A (en) Polyfluoroketone copolymers